flucytosine has been researched along with Leishmaniasis, Cutaneous in 1 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davoudi, N | 1 |
| Khamesipour, A | 1 |
| Mahboudi, F | 1 |
| McMaster, WR | 1 |
1 other study available for flucytosine and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
A dual drug sensitive L. major induces protection without lesion in C57BL/6 mice.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Female; Flucytosine; Ganciclovir; Immunoglobul | 2014 |